RightFit
RecruitingPhase 3

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests how safe a second-generation travoprost implant placed inside the eye is and how well it works. It is for people with high eye pressure or open-angle glaucoma, a disease that can damage the nerve used for sight.

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • The eye being studied has ocular hypertension (high eye pressure) or open-angle glaucoma.

Who can't join

  • The eye being studied had glaucoma surgery that involved a cut in the eye.
  • The eye being studied had argon laser trabeculoplasty (ALT), a laser treatment to lower eye pressure.
  • The eye being studied had minimally invasive glaucoma surgery (MIGS), which uses small cuts or tiny tools.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosis of Ocular Hypertension or Open-Angle Glaucoma in the study eye Exclusion Criteria: * Prior incisional glaucoma surgery in the study eye * Prior argon laser trabeculoplasty (ALT) in the study eye * Prior minimally invasive glaucoma (MIGS) surgery in the study eye

Study sites (1)

AL